SYMPTOMATIC AND FUNCTIONAL RECOVERY INDEX FOR NEGATIVE SYMPTOMS IN A 40-WEEK RANDOMIZED, DOUBLE-BLIND STUDY OF ZIPRASIDONE VERSUS HALOPERIDOL FOLLOWED BY A 3-YEAR DOUBLE-BLIND EXTENSION TRIAL

Stephen M Stahl; Ashok Malla; John W Newcomer; Steven G Potkin; Peter J Weiden; Philip Harvey; Antony Loebel; Eric Watsky; Douglas Vanderburg; Cynthia Siu; Steve Romano

doi:10.1016/j.schres.2010.02.956

Back

SYMPTOMATIC AND FUNCTIONAL RECOVERY INDEX FOR NEGATIVE SYMPTOMS IN A 40-WEEK RANDOMIZED, DOUBLE-BLIND STUDY OF ZIPRASIDONE VERSUS HALOPERIDOL FOLLOWED BY A 3-YEAR DOUBLE-BLIND EXTENSION TRIAL

Journal article

Peer reviewed

SYMPTOMATIC AND FUNCTIONAL RECOVERY INDEX FOR NEGATIVE SYMPTOMS IN A 40-WEEK RANDOMIZED, DOUBLE-BLIND STUDY OF ZIPRASIDONE VERSUS HALOPERIDOL FOLLOWED BY A 3-YEAR DOUBLE-BLIND EXTENSION TRIAL

Stephen M Stahl, Ashok Malla, John W Newcomer, Steven G Potkin, Peter J Weiden, Philip Harvey, Antony Loebel, Eric Watsky, Douglas Vanderburg, Cynthia Siu, …

Schizophrenia research, Vol.117(2-3), pp.502-502

2010-04

DOI: https://doi.org/10.1016/j.schres.2010.02.956

Metrics

10 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: SYMPTOMATIC AND FUNCTIONAL RECOVERY INDEX FOR NEGATIVE SYMPTOMS IN A 40-WEEK RANDOMIZED, DOUBLE-BLIND STUDY OF ZIPRASIDONE VERSUS HALOPERIDOL FOLLOWED BY A 3-YEAR DOUBLE-BLIND EXTENSION TRIAL
Creators: Stephen M Stahl - University of California San Diego, CA, USA
Ashok Malla - McGill University Montreal, Quebec, Canada
John W Newcomer - Washington University St. Louis, Mo, USA
Steven G Potkin - University of California Irvine, CA, USA
Peter J Weiden - University of Illinois Chicago, IL, USA
Philip Harvey - Emory University Atlanta, GA, USA
Antony Loebel - Dainippon Sumitomo Pharma Fort Lee, NJ, USA
Eric Watsky - Pfizer Inc. New York, NY, USA
Douglas Vanderburg - Pfizer Inc. New York, NY, USA
Cynthia Siu - Data Power (DP), Inc. Ringoes, NJ, USA
Steve Romano - Pfizer Inc. New York, NY, USA
Publication Details: Schizophrenia research, Vol.117(2-3), pp.502-502
Publisher: Elsevier B.V
Academic Unit: Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
Language: English
Resource Type: Journal article
Record Identifier: 991031599927402976